1. Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group. (2nd January 2023) Authors: Wechalekar, Ashutosh D.; Cibeira, M. Teresa; Gibbs, Simon D.; Jaccard, Arnaud; Kumar, Shaji; Merlini, Giampaolo; Palladini, Giovanni; Sanchorawala, Vaishali; Schönland, Stefan; Venner, Christopher; Boccadoro, Mario; Kastritis, Efstathios Journal: Amyloid Issue: Volume 30:Number 1(2023) Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Health‐related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study. Issue 6 (30th March 2022) Authors: Sanchorawala, Vaishali; Palladini, Giovanni; Minnema, Monique C.; Jaccard, Arnaud; Lee, Hans C.; Gibbs, Simon; Mollee, Peter; Venner, Christopher; Lu, Jin; Schönland, Stefan; Gatt, Moshe; Suzuki, Kenshi; Kim, Kihyun; Cibeira, María Teresa; Beksac, Meral; Libby, Edward; Valent, Jason; Hungria, Van... Journal: American journal of hematology Issue: Volume 97:Issue 6(2022) Page Start: 719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Peripheral neuropathy symptoms, pain, and functioning in previously treated multiple myeloma patients treated with selinexor, bortezomib, and dexamethasone. Issue 10 (12th July 2021) Authors: Sanchez, Larysa; Leleu, Xavier; Beaumont, Jennifer L.; Yu, Hailin; Hudgens, Stacie; Simonova, Maryana; Auner, Holger W.; Quach, Hang; Delimpasi, Sosana; Špička, Ivan; Pour, Ludĕk; Kriachok, Iryna; Dimopoulos, Meletios A.; Usenko, Ganna; Hájek, Roman; Benjamin, Reuben; Sinha, Dinesh Kumar; Venner,... Journal: American journal of hematology Issue: Volume 96:Issue 10(2021) Page Start: E383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Real‐world outcomes with bortezomib‐containing regimens and lenalidomide plus dexamethasone for the treatment of transplant‐ineligible multiple myeloma: a multi‐institutional report from the Canadian Myeloma Research Group database. (9th February 2021) Authors: Jimenez‐Zepeda, Victor H.; Venner, Christopher; McCurdy, Arleigh; Masih‐Khan, Esther; Atenafu, Eshetu G.; Sebag, Michael; Stakiw, Julie; Song, Kevin; LeBlanc, Richard; Reiman, Tony; Louzada, Martha; Kotb, Rami; Gul, Engin; Reece, Donna Journal: British journal of haematology Issue: Volume 193:Number 3(2021) Page Start: 532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗